“We believe any stock run-up attributed to this news flow should come off,” said brokerage Emkay Global’s analysts Anand Dama, Kunaal N, and Marazbaan Dastur in a client note. “This raised hopes for the replacement… with a pedigreed external candidate from a large bank as MD.”
Drug companies in pink of health, further upside expected
Nifty’s Pharma and Healthcare indices have gained 1.7% and 2.6% respectively in the past month, while the benchmark Nifty declined 2% in this period.
December 25, 2024